Hyloris Lines Up FDA Filing For Valacyclovir Oral Suspension

Also Adds Rights In New Markets As Clinical Trial Delivers Positive Results

 
• By David Wallace
  
Sign outside of FDA's headquarters in White Oak, MD
Hyloris is planning an FDA filing by the end of the year • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Value Added Medicines

More from Products